[FOLFOX-related hypersensitivity reactions: clinical presentation and management].
Division of Pharmacy, National Cancer Center Hospital.
Takako
T
Yanai
Satoru
S
Iwasa
Yasuhide
Y
Yamada
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D015179:Colorectal Neoplasms / Q000188:drug therapy; D004342:Drug Hypersensitivity / Q000517:prevention & control / Q000628:therapy*; D005472:Fluorouracil / Q000009:adverse effects; D006801:Humans; D002955:Leucovorin / Q000009:adverse effects; D009944:Organoplatinum Compounds / Q000009:adverse effects
D009944:Organoplatinum Compounds; D002955:Leucovorin; D005472:Fluorouracil